Skip to main content
Top
Published in: Infection 5/2019

01-10-2019 | Tick | Review

Tularemia: an experience of 13 cases including a rare myocarditis in a referral center in Eastern Switzerland (Central Europe) and a review of the literature

Authors: Manuel Frischknecht, Angelina Meier, Bernhard Mani, Lucas Joerg, Olaf Chan-Hi Kim, Katia Boggian, Carol Strahm

Published in: Infection | Issue 5/2019

Login to get access

Abstract

Background

Tularemia, a zoonotic disease caused by Francisella tularensis, can cause a broad spectrum of disease in humans including six major clinical presentations: the ulceroglandular, glandular, oculoglandular, oropharyngeal, typhoidal and pneumonic form. The epidemiology and ecology and thus transmission of tularemia are complex, depending on conditions unique to specific locations.

Case series and methods

Thirteen cases with different forms of the disease and one very rare case of a myocarditis are reported, discussed, and reviewed within the scope of current literature.

Conclusion

Tularemia is a rare, but emerging disease in Central Europe with glandular and ulceroglandular disease as its predominant forms. Transmission is mainly caused by contact with lagomorphs, rodents and tick bites. However, domestic cats may play an important role in transmission too. Myocarditis is probably a worldwide, but very rare manifestation of tularemia.
Literature
1.
go back to reference Ellis J, Oyston PCF, Green M, Titball RW. Tularemia. Clin Microbiol Rev. 2002;15:631–46.CrossRef Ellis J, Oyston PCF, Green M, Titball RW. Tularemia. Clin Microbiol Rev. 2002;15:631–46.CrossRef
8.
go back to reference Jackson J, McGregor A, Cooley L, Ng J, Brown M, Ong CW, et al. Francisella tularensis subspecies holarctica, Tasmania, Australia, 2011. Emerg Infect Dis. 2012;18:1484–6.CrossRef Jackson J, McGregor A, Cooley L, Ng J, Brown M, Ong CW, et al. Francisella tularensis subspecies holarctica, Tasmania, Australia, 2011. Emerg Infect Dis. 2012;18:1484–6.CrossRef
9.
go back to reference Maurin M, Gyuranecz M. Tularaemia: clinical aspects in Europe. Lancet Infect Dis. 2016;16:113–24.CrossRef Maurin M, Gyuranecz M. Tularaemia: clinical aspects in Europe. Lancet Infect Dis. 2016;16:113–24.CrossRef
11.
go back to reference Farlow J, Wagner DM, Dukerich M, Stanley M, Chu M, Kubota K, et al. Francisella tularensis in the United States. Emerg Infect Dis. 2005;11:1835–41.CrossRef Farlow J, Wagner DM, Dukerich M, Stanley M, Chu M, Kubota K, et al. Francisella tularensis in the United States. Emerg Infect Dis. 2005;11:1835–41.CrossRef
12.
go back to reference Alias T, Fallahzadeh MK, Berhe M. Tularemia presenting as pulmonary nodules in an immunocompromised patient. Bayl Univ Med Cent Proc. 2017;30:175–6.CrossRef Alias T, Fallahzadeh MK, Berhe M. Tularemia presenting as pulmonary nodules in an immunocompromised patient. Bayl Univ Med Cent Proc. 2017;30:175–6.CrossRef
13.
go back to reference Franzen D, Müller F, Bode PK. Lung mass and tularaemia. QJM. 2016;109:417–8.CrossRef Franzen D, Müller F, Bode PK. Lung mass and tularaemia. QJM. 2016;109:417–8.CrossRef
14.
go back to reference Odegaard K, Boersma B, Keegan J. Atypical presentations of tularemia. S D Med U S. 2017;70:207–9. Odegaard K, Boersma B, Keegan J. Atypical presentations of tularemia. S D Med U S. 2017;70:207–9.
15.
go back to reference Naughton M, Brown R, Adkins D, DiPersio J. Tularemia—an unusual cause of a solitary pulmonary nodule in the post-transplant setting. Bone Marrow Transpl. 1999;24:197–9.CrossRef Naughton M, Brown R, Adkins D, DiPersio J. Tularemia—an unusual cause of a solitary pulmonary nodule in the post-transplant setting. Bone Marrow Transpl. 1999;24:197–9.CrossRef
16.
go back to reference Fachinger P, Tini GM, Grobholz R, Gambazzi F, Fankhauser H, Irani S. Pulmonary tularaemia: all that looks like cancer is not necessarily cancer—case report of four consecutive cases. BMC Pulm Med. 2015;15:1–6.CrossRef Fachinger P, Tini GM, Grobholz R, Gambazzi F, Fankhauser H, Irani S. Pulmonary tularaemia: all that looks like cancer is not necessarily cancer—case report of four consecutive cases. BMC Pulm Med. 2015;15:1–6.CrossRef
17.
go back to reference Genchi M, Prati P, Vicari N, Manfredini A, Sacchi L, Clementi E, et al. Francisella tularensis: no evidence for transovarial transmission in the tularemia tick vectors dermacentor reticulatus and ixodes ricinus. PLoS One. 2015;10:e0133593.CrossRef Genchi M, Prati P, Vicari N, Manfredini A, Sacchi L, Clementi E, et al. Francisella tularensis: no evidence for transovarial transmission in the tularemia tick vectors dermacentor reticulatus and ixodes ricinus. PLoS One. 2015;10:e0133593.CrossRef
18.
go back to reference Johansson A, Lärkeryd A, Widerström M, Mörtberg S, Myrtännäs K, Öhrman C, et al. An outbreak of respiratory tularemia caused by diverse clones of Francisella tularensis. Clin Infect Dis. 2014;59:1546–53.CrossRef Johansson A, Lärkeryd A, Widerström M, Mörtberg S, Myrtännäs K, Öhrman C, et al. An outbreak of respiratory tularemia caused by diverse clones of Francisella tularensis. Clin Infect Dis. 2014;59:1546–53.CrossRef
19.
go back to reference Eliasson H, Lindbäck J, Pekka Nuorti J, Arneborn M, Giesecke J, Tegnell A. The 2000 tularemia outbreak: a case-control study of risk factors in disease-endemic and emergent areas, Sweden. Emerg Infect Dis. 2002;8:956–60.CrossRef Eliasson H, Lindbäck J, Pekka Nuorti J, Arneborn M, Giesecke J, Tegnell A. The 2000 tularemia outbreak: a case-control study of risk factors in disease-endemic and emergent areas, Sweden. Emerg Infect Dis. 2002;8:956–60.CrossRef
20.
go back to reference Capellan J, Fong IW. Tularemia from a cat bite: case report and review of feline-associated tularemia. Clin Infect Dis. 1928;16:472–5.CrossRef Capellan J, Fong IW. Tularemia from a cat bite: case report and review of feline-associated tularemia. Clin Infect Dis. 1928;16:472–5.CrossRef
22.
go back to reference Larson MA, Fey PD, Hinrichs SH, Iwen PC. Francisella tularensis bacteria associated with feline tularemia in the United States. Emerg Infect Dis. 2014;20:2068–71.CrossRef Larson MA, Fey PD, Hinrichs SH, Iwen PC. Francisella tularensis bacteria associated with feline tularemia in the United States. Emerg Infect Dis. 2014;20:2068–71.CrossRef
23.
go back to reference Shaw SE, Birtles RJ, Day MJ. Arthropod-transmitted infectious diseases of cats. J Feline Med Surg. 2001;3:193–209.CrossRef Shaw SE, Birtles RJ, Day MJ. Arthropod-transmitted infectious diseases of cats. J Feline Med Surg. 2001;3:193–209.CrossRef
25.
go back to reference Ernst M, Pilo P, Fleisch F, Glisenti P. Tularemia in the Southeastern Swiss Alps at 1,700 m above sea level. Infection. 2015;43:111–5.CrossRef Ernst M, Pilo P, Fleisch F, Glisenti P. Tularemia in the Southeastern Swiss Alps at 1,700 m above sea level. Infection. 2015;43:111–5.CrossRef
26.
go back to reference Tärnvik A, Chu MC. New approaches to diagnosis and therapy of tularemia. Ann N Y Acad Sci. 2007;404:378–404.CrossRef Tärnvik A, Chu MC. New approaches to diagnosis and therapy of tularemia. Ann N Y Acad Sci. 2007;404:378–404.CrossRef
27.
go back to reference Lamps LW, Havens JM, Sjostedt A, Page DL, Scott MA Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America. Mod Pathol. 2004;17:489–95.CrossRef Lamps LW, Havens JM, Sjostedt A, Page DL, Scott MA Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America. Mod Pathol. 2004;17:489–95.CrossRef
29.
go back to reference Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. Tularemia as a biological weapon: medical and public health management. JAMA U S. 2001;285:2763–73.CrossRef Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, et al. Tularemia as a biological weapon: medical and public health management. JAMA U S. 2001;285:2763–73.CrossRef
30.
go back to reference WHO guidelines on tularaemia. WHO Libr. Cat. Data. 2007. WHO guidelines on tularaemia. WHO Libr. Cat. Data. 2007.
31.
go back to reference Caspar Y, Hennebique A, Maurin M. Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016. J Antimicrob Chemother Engl. 2017;73:687–91.CrossRef Caspar Y, Hennebique A, Maurin M. Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016. J Antimicrob Chemother Engl. 2017;73:687–91.CrossRef
32.
go back to reference Tomaso H, Hotzel H, Otto P, Myrtennas K, Forsman M. Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany. J Antimicrob Chemother England. 2017;72:2539–43.CrossRef Tomaso H, Hotzel H, Otto P, Myrtennas K, Forsman M. Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany. J Antimicrob Chemother England. 2017;72:2539–43.CrossRef
33.
go back to reference Ulu-Kilic A, Gulen G, Sezen F, Kilic S, Sencan I. Tularemia in central Anatolia. Infect Ger. 2013;41:391–9.CrossRef Ulu-Kilic A, Gulen G, Sezen F, Kilic S, Sencan I. Tularemia in central Anatolia. Infect Ger. 2013;41:391–9.CrossRef
34.
go back to reference Meric M, Willke A, Finke E-J, Grunow R, Sayan M, Erdogan S, et al. Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia. APMIS Den. 2008;116:66–73.CrossRef Meric M, Willke A, Finke E-J, Grunow R, Sayan M, Erdogan S, et al. Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia. APMIS Den. 2008;116:66–73.CrossRef
35.
go back to reference Pérez-Castrillón JL, Bachiller-Luque P, Martín-Luquero M, Mena-Martín FJ, Herreros V. Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. Clin Infect Dis U S. 2001;33:573–6.CrossRef Pérez-Castrillón JL, Bachiller-Luque P, Martín-Luquero M, Mena-Martín FJ, Herreros V. Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. Clin Infect Dis U S. 2001;33:573–6.CrossRef
36.
go back to reference Enderlin G, Morales L, Jacobs RF, Cross JT. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis. 1994;19:42–7.CrossRef Enderlin G, Morales L, Jacobs RF, Cross JT. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis. 1994;19:42–7.CrossRef
37.
go back to reference Penn RL, Kinasewitz GT. Factors associated with a poor outcome in tularemia. Arch Intern Med U S. 1987;147:265–8.CrossRef Penn RL, Kinasewitz GT. Factors associated with a poor outcome in tularemia. Arch Intern Med U S. 1987;147:265–8.CrossRef
38.
go back to reference Eliasson H, Back E. Tularaemia in an emergent area in Sweden: an analysis of 234 cases in five years. Scand J Infect Dis Engl. 2007;39:880–9.CrossRef Eliasson H, Back E. Tularaemia in an emergent area in Sweden: an analysis of 234 cases in five years. Scand J Infect Dis Engl. 2007;39:880–9.CrossRef
39.
go back to reference Risi GF, Pombo DJ. Relapse of tularemia after aminoglycoside therapy: case report and discussion of therapeutic options. Clin Infect Dis U S. 1995;20:174–5.CrossRef Risi GF, Pombo DJ. Relapse of tularemia after aminoglycoside therapy: case report and discussion of therapeutic options. Clin Infect Dis U S. 1995;20:174–5.CrossRef
40.
go back to reference Origgi FC, Frey J, Pilo P. Characterisation of a new group of Francisella tularensis subsp. holarctica in Switzerland with altered antimicrobial susceptibilities, 1996 to 2013. Eurosurveillance 2014;19:1–10.CrossRef Origgi FC, Frey J, Pilo P. Characterisation of a new group of Francisella tularensis subsp. holarctica in Switzerland with altered antimicrobial susceptibilities, 1996 to 2013. Eurosurveillance 2014;19:1–10.CrossRef
41.
go back to reference Borde JP, Zange S, Antwerpen MH, Georgi E, von Buttlar H, Kern WV, et al. Five cases of vector-borne Francisella tularensis holarctica infections in south-western Germany and genetic diversity. Ticks Tick Borne Dis Neth. 2017;8:808–12.CrossRef Borde JP, Zange S, Antwerpen MH, Georgi E, von Buttlar H, Kern WV, et al. Five cases of vector-borne Francisella tularensis holarctica infections in south-western Germany and genetic diversity. Ticks Tick Borne Dis Neth. 2017;8:808–12.CrossRef
42.
go back to reference Dentan C, Pavese P, Pelloux I, Boisset S, Brion J-P, Stahl J-P, et al. Treatment of tularemia in pregnant woman. Fr Emerg Infect Dis U S. 2013;19:996–8.CrossRef Dentan C, Pavese P, Pelloux I, Boisset S, Brion J-P, Stahl J-P, et al. Treatment of tularemia in pregnant woman. Fr Emerg Infect Dis U S. 2013;19:996–8.CrossRef
43.
go back to reference Maurin M, Pelloux I, Brion JP, Del Bano J-N, Picard A. Human tularemia in France, 2006–2010. Clin Infect Dis U S. 2011;53:e133-41. Maurin M, Pelloux I, Brion JP, Del Bano J-N, Picard A. Human tularemia in France, 2006–2010. Clin Infect Dis U S. 2011;53:e133-41.
44.
go back to reference Johansson A, Berglund L, Sjöstedt A, Tärnvik A. Ciprofloxacin for treatment of tularemia. Clin Infect Dis U S. 2001;33:267–8.CrossRef Johansson A, Berglund L, Sjöstedt A, Tärnvik A. Ciprofloxacin for treatment of tularemia. Clin Infect Dis U S. 2001;33:267–8.CrossRef
45.
go back to reference Syrjala H, Schildt R, Raisainen S. In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin. Eur J Clin Microbiol Infect Dis Ger. 1991;10:68–70.CrossRef Syrjala H, Schildt R, Raisainen S. In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin. Eur J Clin Microbiol Infect Dis Ger. 1991;10:68–70.CrossRef
46.
go back to reference Bloch-Infanger C, Furrer K, Wiese M, Hiebinger A, Bucher CM, Kopp S, et al. An unexpected cause for cavitary pneumonia and empyema. Infect Ger. 2016;44:539–41.CrossRef Bloch-Infanger C, Furrer K, Wiese M, Hiebinger A, Bucher CM, Kopp S, et al. An unexpected cause for cavitary pneumonia and empyema. Infect Ger. 2016;44:539–41.CrossRef
47.
go back to reference Celebi G, Baruonu F, Ayoglu F, Cinar F, Karadenizli A, Ugur MB, et al. Tularemia, a reemerging disease in northwest Turkey: epidemiological investigation and evaluation of treatment responses. Jpn J Infect Dis Jpn. 2006;59:229–34. Celebi G, Baruonu F, Ayoglu F, Cinar F, Karadenizli A, Ugur MB, et al. Tularemia, a reemerging disease in northwest Turkey: epidemiological investigation and evaluation of treatment responses. Jpn J Infect Dis Jpn. 2006;59:229–34.
48.
go back to reference Passiouk N, Heininger U. Ulceroglandular tularemia following contact with a boar. Pediatr Infect Dis J U S. 2016;35:453–5.CrossRef Passiouk N, Heininger U. Ulceroglandular tularemia following contact with a boar. Pediatr Infect Dis J U S. 2016;35:453–5.CrossRef
49.
go back to reference Franco Hidalgo S, Prieto de Paula JM, Balaguer Zubieta I, Alvarez Ruiz AP. Infection due to Francisella tularensis, myocarditis and dilated myocardiopathy. Enferm Infecc Microbiol Clin. 2010;28:752–3.CrossRef Franco Hidalgo S, Prieto de Paula JM, Balaguer Zubieta I, Alvarez Ruiz AP. Infection due to Francisella tularensis, myocarditis and dilated myocardiopathy. Enferm Infecc Microbiol Clin. 2010;28:752–3.CrossRef
50.
go back to reference Amort J, Karrer U. Zwei Fallbeispiele zur Tularämie: eine typische und eine atypische Verlaufsform. BAG Bull. 2013;(49/13):896 Amort J, Karrer U. Zwei Fallbeispiele zur Tularämie: eine typische und eine atypische Verlaufsform. BAG Bull. 2013;(49/13):896
51.
go back to reference Gore I, Saphir O. myocarditis a classification of 1402 cases. Am Heart J. 1947;34(6):827–30.CrossRef Gore I, Saphir O. myocarditis a classification of 1402 cases. Am Heart J. 1947;34(6):827–30.CrossRef
54.
go back to reference Aaagard GN. Involvement of the heart in tularemia. Minn Med. 1944;27:115–21 Aaagard GN. Involvement of the heart in tularemia. Minn Med. 1944;27:115–21
56.
go back to reference Ilback NG, Friman G, Beisel WR, Johnson AJ. Sequential metabolic alterations in the myocardium during influenza and tularemia in mice. Infect Immun. 1984;45:491–7.PubMedPubMedCentral Ilback NG, Friman G, Beisel WR, Johnson AJ. Sequential metabolic alterations in the myocardium during influenza and tularemia in mice. Infect Immun. 1984;45:491–7.PubMedPubMedCentral
Metadata
Title
Tularemia: an experience of 13 cases including a rare myocarditis in a referral center in Eastern Switzerland (Central Europe) and a review of the literature
Authors
Manuel Frischknecht
Angelina Meier
Bernhard Mani
Lucas Joerg
Olaf Chan-Hi Kim
Katia Boggian
Carol Strahm
Publication date
01-10-2019
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2019
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-019-01269-7

Other articles of this Issue 5/2019

Infection 5/2019 Go to the issue